Heart Test Laboratories
HSCS
5 hedge funds and large institutions have $66.3K invested in Heart Test Laboratories in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
1,127% more capital invested
Capital invested by funds: $5.4K → $66.3K (+$60.9K)
67% more funds holding
Funds holding: 3 → 5 (+2)
2.03% more ownership
Funds ownership: 0.14% → 2.18% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASW
Astoria Strategic Wealth
Conroe,
Texas
|
+$63.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.41K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.29K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.84K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$3 |
Top Sellers
HSCS Hedge Fund Activity: Q1 2025 in Review
5 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q1 2025, worth a combined $66.3K — up 1,127% from $5.4K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new HSCS positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Astoria Strategic Wealth, opening a new position worth an estimated $63.3K.
- 5 institutional investors held Heart Test Laboratories (HSCS) as of Q1 2025, up from 3 in Q4 2024.
- Funds reported $66.3K of Heart Test Laboratories stock for Q1 2025, up 1,127% quarter-over-quarter.
- 2 funds opened new Heart Test Laboratories positions in Q1 2025 and 0 closed out, a net change of +2 holders.
- The largest Heart Test Laboratories buyer in Q1 2025 was Astoria Strategic Wealth, an estimated $63.3K added.
Based on aggregated 13F filings for Q1 2025.